AVIR Operating Cash Flow (Statement)
Atea Pharmaceuticals Inc · Operating Cash Flow (Statement)
AVIR Operating Cash Flow (Statement)
Latest reported-$37.08Mperiod ending
AVIR Quarterly Cash from Operations (-$3.32M → -$37.08M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
AVIR operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -37,084,000 | |
| -46,391,000 | |
| -28,223,000 | |
| -40,375,000 | |
| -32,870,000 | |
| -30,563,000 | |
| -30,397,000 | |
| -23,035,000 | |
| -42,202,000 | |
| -39,865,000 | |
| -21,834,000 | |
| -17,591,000 | |
| -16,120,000 | |
| -29,850,000 | |
| -21,545,000 | |
| -21,242,000 | |
| -19,186,000 | |
| -59,009,000 | |
| -75,423,000 | |
| 22,603,000 | |
| -17,348,000 | |
| -16,837,000 | |
| 318,521,000 | |
| -9,481,000 | |
| -7,798,000 | |
| -4,508,000 | |
| -3,928,000 | |
| -3,679,000 | |
| -1,892,000 | |
| -3,315,000 |